Asthma (Diagnosis)NCT07480616
Efficacy of Indonesian Asthmatic Gymnastic as Combine Pulmonary Rehabilitation Based on Asthma Classification
A study testing Indonesian Asthma Gymnastic exercise in people with Asthma (Diagnosis) and Adult, run by RSUP Persahabatan at 1 site in Indonesia.
Trial summary
This study aims to evaluate the efficacy of Indonesian Asthma Gymnastic for stable asthmatic patients in all asthma classification. The outcome measurements includes 6 minutes walk test, Asthma Control Test, peak flow rate value, and lung function. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Asthma (Diagnosis), Adult
- What is being tested?
- Indonesian Asthma Gymnastic exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 35 participants
- Where
- 1 siteIndonesia
- Study dates
- 6 Oct 2025to Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosed with stable asthma
- Age 18-65 years old
- Competent and willing to be included in the trial
Who cannot join
- Asthma exacerbation
- Had other lung disease
- Had neuromuscular disease affecting respiratory system
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Indonesia1 site, 1 recruiting
- Recruiting
RSUP Persahabatan
Jakarta
RSUP Persahabatan, +62 87857355235, veronikarennykurniawati@gmail.com
Siti C Widjanantie, +62 81348639827
About this study
Official title: EFFICACY OF INDONESIAN ASTHMATIC GYMNASTIC AS COMBINE PULMONARY REHABILITATION IN ASTHMATIC PATIENT BASED ON ASTHMA CLASSIFICATION
This study aims to evaluate the efficacy of Indonesian Asthma Gymnastic for stable asthmatic patients in all asthma classification. The outcome measurements includes 6 minutes walk test, Asthma Control Test, peak flow rate value, and lung function. All participants have been in routine standard treatment of asthma (medication, education of healthy life style and smoking cessation).
- Conditions
- Asthma (Diagnosis), Adult
- Being tested
- Indonesian Asthma Gymnastic exercise
- Medical subject headings
- Asthma, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Indonesian Asthma Gymnastic exerciseOther
Aerobic structured exercise designed for asthmatic patient consists of 8 phase: warming up, stretching, core movement I, core movement II, aerobics I-III, and cooling down
| Study group | Role | What they receive |
|---|---|---|
| Experimental: IAG group | Experimental | Not described Receives: Other: Indonesian Asthma Gymnastic exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in 6 minutes walk distance
Measured: Baseline, 4 weeks
Asthma Control Test score
Measured: Baseline, 4 weeks
Change in Forced Expiratory Volume in 1 second, Forced Vital Capacity, and FEV1/FVC ratio
Measured: Baseline, 4 weeks
Secondary outcomes (1)
Change of peak flow rate
Measured: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Mar 2026
- Study start6 Oct 2025
- Primary completionJul 2026 (estimated)
- Study completionSep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Asthma (Diagnosis)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 35 participants (estimated)
Sponsor and investigators
- Lead sponsor
- RSUP Persahabatan
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07480616
- Sponsor's protocol ID
- 0135/KEPK-RSUPP/07/2025
- Status last verified
- Mar 2026
- First submitted
- 13 Mar 2026
- Last updated
- 18 Mar 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- EFFICACY OF INDONESIAN ASTHMATIC GYMNASTIC AS COMBINE PULMONARY REHABILITATION IN ASTHMATIC PATIENT BASED ON ASTHMA CLASSIFICATION
- ClinicalTrials.gov ID
- NCT07480616
- Acronym / sponsor ID
- 0135/KEPK-RSUPP/07/2025
- Conditions
- Asthma (Diagnosis), Adult
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 35 participants (estimated)
- Lead sponsor
- RSUP PersahabatanUniversity, hospital or other
- Study start
- 6 Oct 2025 (actual)
- Primary completion
- Jul 2026 (estimated)
- Study completion
- Sep 2026 (estimated)
- First posted
- 18 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the efficacy of Indonesian Asthma Gymnastic for stable asthmatic patients in all asthma classification. The outcome measurements includes 6 minutes walk test, Asthma Control Test, peak flow rate value, and lung function. All participants have been in routine standard treatment of asthma (medication, education of healthy life style and smoking cessation).
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Experimental: IAG group | Experimental | Other: Indonesian Asthma Gymnastic exercise |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Diagnosed with stable asthma
- Age 18-65 years old
- Competent and willing to be included in the trial
Key exclusion criteria (3 listed)
- Asthma exacerbation
- Had other lung disease
- Had neuromuscular disease affecting respiratory system
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Indonesian Asthma Gymnastic exerciseAerobic structured exercise designed for asthmatic patient consists of 8 phase: warming up, stretching, core movement I, core movement II, aerobics I-III, and cooling down | Other | Experimental: IAG group |
Primary outcome
Change in 6 minutes walk distance
Time frame: Baseline, 4 weeks
Asthma Control Test score
Time frame: Baseline, 4 weeks
Change in Forced Expiratory Volume in 1 second, Forced Vital Capacity, and FEV1/FVC ratio
Time frame: Baseline, 4 weeks
1 secondary outcome
Change of peak flow rate
Time frame: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Mar 2026.
Related trials for Asthma (Diagnosis)
RecruitingPhase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Asthma
RecruitingPhase 1
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Asthma, Mild Asthma
RecruitingPhase 3
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control
Active, not recruitingPhase 2/3
Local Antibiotic Delivery for Community Acquired Pneumonia
Community Acquired Pneumonia (CAP)
RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Indonesian Asthma Gymnastic exercise in people with Asthma (Diagnosis) and Adult, run by RSUP Persahabatan at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Veronika R Kurniawati (+62 87857355235, veronikarennykurniawati@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in 6 minutes walk distance (time frame: Baseline, 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.